Clinical trial Recruiting at 1 site Interventional

Optimizing A1c and TSH Test Orders with Clinical Decision Support

Official title: Evaluation of Our Practice Advisory (OPA) Interventions on Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Short Interval Ordering

Run by University of California, Los Angeles · NCT06993805 · Data updated 2026-11-12

This study is testing a new alert system to help doctors decide when to order blood tests for diabetes and thyroid function, aiming to reduce unnecessary repeat tests and improve patient care.

Quick facts

Study typeInterventional
SexAll
Enrollment384 (estimated)
SponsorUniversity of California, Los Angeles
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedMay 6, 2025
Main results expectedDecember 2025
Study endsFebruary 2026
Registry record updatedMay 29, 2025
Trial IDNCT06993805 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have had A1c or TSH tests ordered within the prior 30 days during their inpatient or observation stays at UCLA Health System hospitals.

Probably not a fit

Patients who have not had a result for A1c or TSH tests ordered in the prior 30 days will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative evaluates the impact of a randomized Our Practice Advisory (OPA) intervention on physician ordering behavior for Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) tests. The OPA alerts providers when these tests are ordered within 30 days of a prior result, encouraging them to reconsider unnecessary repeat testing. By focusing on optimizing resource use and aligning test orders with evidence-based guidelines, the study aims to improve patient outcomes and inform broader clinical decision support strategies. The results will help determine if the OPA should be implemented across all patients and potentially extended to other laboratory tests.

Why it matters

Potential benefit: If successful, this approach could reduce unnecessary testing and improve patient care by ensuring more appropriate test ordering.

How similar studies have gone: Other studies have shown success with similar clinical decision support interventions, indicating potential for positive outcomes in optimizing test ordering.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* Inpatient or observation stays within UCLA Health System hospitals
* Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) ordered, AND this lab was ordered and resulted within the prior 30 days

Exclusion Criteria:

* Have an A1c or TSH ordered and do not have a result for one of these labs in the prior 30 days

Where it's running

  • UCLA Health System
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.